Phenotype–genotype correlations in patients with TGFBI-linked corneal dystrophies in Taiwan by Hou, Yu-Chih et al.
Phenotype–genotype correlations in patients with TGFBI-linked
corneal dystrophies in Taiwan
Yu-Chih Hou,1 I-Jong Wang,1 Cheng-Hsiang Hsiao,2 Wei-Li Chen,1 Fung-Rong Hu1
1Department of Ophthalmology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei,
Taiwan; 2Department of Pathology, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei,
Taiwan
Purpose: To determine the phenotype–genotype correlations in patients with corneal dystrophies associated with human
transforming growth factor-β-induced (TGFBI) mutations at the National Taiwan University Hospital.
Methods: Twenty-five affected patients from 15 families with corneal dystrophies were recruited. They underwent slit-
lamp biomicroscopy and visual acuity examinations. Genomic DNA was extracted from their peripheral blood, and the
exons amplified from TGFBI were sequenced.
Results: Eleven patients from 9 families with granular corneal dystrophy (GCD) presented with a wide spectrum of dot
or fleck opacities and shared some similar clinical features. Genetic studies revealed an R124H mutation in 5 families and
an R555W mutation in 4 families. A patient with GCD type 2 and an R124H mutation showed a marked increase in
opacities in the laser-assisted in situ keratomileusis (LASIK) flap interface. Six patients from 3 families with superficial
honeycomb opacities had an R555Q mutation. Of the 4 patients from 3 families with variant lattice line opacities, 3 from
2 families had an R124C mutation, whereas 1 from the third family had an A546D mutation. Spontaneous mutations were
detected in 2 families: an R124C mutation in 1 family with lattice corneal dystrophy (LCD) type I and an A546D mutation
in the other with atypical LCD.
Conclusions: In most cases, TGFBI-linked corneal dystrophies had good phenotype–genotype correlations; however,
some phenotypic variation was present. The most common mutations in Taiwan were R124H in GCD type 2 and R555W
in GCD type 1. The R555Q mutation in Thiel–Behnke corneal dystrophy is not as rare in Taiwan as it is in other Asian
countries. Sequencing of TGFBI can aid in the precise classification of these corneal dystrophies.
Corneal  dystrophies  are  a  heterogeneous  group  of
inherited,  bilaterally  progressive  corneal  opacities  without
inflammation.  These  variable  opacities  often  result  in
recurrent corneal erosion and visual impairment. Most corneal
dystrophies show an autosomal dominant inheritance pattern
with a high degree of penetrance. Three autosomal dominant
corneal dystrophies, including granular dystrophy Groenouw
type I (GCD1), lattice type I (LCD1), and Avellino (ACD or
GCD2), have been mapped to chromosome 5q31 [1]. GCD1
is characterized by bread crumb- or snowflake-like opacities
that stain positive on Masson trichrome staining [2]. LCD1 is
primary  amyloidosis  characterized  by  linear  or  branching
stromal opacities, which stain positive on staining with Congo
red and are birefringent under polarized light [3]. GCD2 is
characterized  by  the  coexistence  of  granular  deposits  and
amyloid deposits [4,5]. Corneal opacities of these 3 corneal
dystrophies often develop in childhood and gradually progress
to cause visual impairment between the third and fifth decades
of life. The transforming growth factor β-induced (TGFBI)
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gene, which is expressed in the corneal epithelium and stromal
keratocytes, was mapped to the chromosome 5q31 locus [6].
In  1997,  Munier  et  al.  [7]  reported  4  different  missense
mutations in TGFBI at the CpG dinucleotide of 2 arginine
codons:  an  R555W  mutation  in  a  family  with  GCD1,  an
R555Q  mutation  in  a  family  with  Reis-Bücklers  corneal
dystrophy (RBCD), an R124C mutation in 2 families with
LCD1, and an R124H mutation in 2 families with GCD2. In
retrospect,  the  phenotype  of  the  family  with  the  R555Q
mutation  should  have  been  designated  as  Thiel–Behnke
corneal  dystrophy  (TBCD)  instead  of  RBCD  because  the
original  form  of  RBCD  is  characterized  by  confluent
geographic  opacities,  and  TBCD  is  characterized  by
honeycomb-shaped  opacities.  RBCD  and  TBCD  are  also
called corneal dystrophy of Bowman’s layer type 1 (CDB1)
and type 2 (CDB2), respectively. These are caused by R124L
and R555Q mutations in TGFBI, respectively [8,9]. A wide
range of variant stromal/Bowman’s layer corneal dystrophies
has  been  found  to  be  associated  with  different  TGFBI
mutations. At present, more than 50 mutations have been
identified in TGFBI, with R124 and R555 being the most
frequent sites of mutation in various populations. Although a
good correlation has been observed between genotype and
phenotype—R555W in GCD1, R124C in LCD1, R124H in
GCD2,  R124L  in  RBCD,  and  R555Q  in  TBCD—some
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362families having corneal dystrophies with TGFBI mutations
have  been  reported  to  have  variant  phenotypes  [10,11].
Clinical presentation may not be sufficient to classify these
stromal/Bowman’s  layer  corneal  dystrophies.  Hence,
screening  for  mutations  in  TGFBI  may  facilitate  the
classification of corneal dystrophies, especially in the cases
of atypical clinical presentations.
In this study, we aimed to identify the clinical features
and genetic mutation spectrum in patients with TGFBI-linked
corneal  dystrophies  from  the  National  Taiwan  University
Hospital,  Taipei,  a  tertiary-care  referral  medical  center  in
northern Taiwan. Although genetic studies on TGFBI-linked
corneal dystrophies have been reported in several populations,
no large genetic studies have been reported in the Taiwanese
population  [12].  The  correlations  between  phenotype  and
genotype  may  differ  across  different  ethnic  backgrounds;
therefore, detection of the characteristics of TGFBI mutations
in specific populations is important. This may increase our
understanding  of  the  clinical–molecular  correlations  in
TGFBI.
METHODS
Subjects:  Twenty-five  affected  patients  with  corneal
dystrophies from 15 unrelated families were recruited from
National  Taiwan  University  Hospital.  The  study  was
performed in accordance with the tenets of the Declaration of
Helsinki and was approved by the Research Ethic Committee
of the National Taiwan University Hospital. Informed consent
TABLE 1. POLYMERASE CHAIN REACTION PRIMERS FOR THE 17 EXONS OF THE TGFBI GENE.
Exon Sequences of primers
1 F: 5′-CCGCTCGCAGCTTACTTAAC-3′
  R: 5′-AGCGCTCCATGCTGCAAGGT-3′
2 F: 5′-GTGGACGTGCTGATCATCTT-3′
  R: 5′-TCCTGGCTGGTTACAGATAC-3′
3 F: 5′-GCTGTGGAGGCAACTTAGTG-3′
  R: 5′-GAGAATGCCATGTCCTTGTG-3′
4 F: 5′-CCCCAGAGGCCATCCCTCCT-3′
  R: 5′-CCGGGCAGACGGAGGTCATC-3′
5 F: 5′-TCCTTAGGAAGTGCTGGACT-3′
  R: 5′-CCCCTACCCCATTAGGATAG-3′
6 F: 5′-TGGGCAGATTGTAACTGTGA-3′
  R: 5′-CCCTTACCCGAAGGGTCTCA-3′
7 F: 5′-CCCACAGGCTGCTCTGGCTG-3′
  R: 5′-TGCTCACCTCTCAGGGCTTC-3′
8 F: 5′-ACCCCAGACCTGCTGAACAA-3′
  R: 5′-GGCCTACCTGAGTCTGGGAT-3′
9 F: 5′-CTTGTAGCCAAGAGCACTATT-3′
  R: 5′-ATGTTACCTTTGAATACAGA-3′
10 F: 5′-CTTGTAGATGGAACCCCTCC-3′
  R: 5′-AACTTACATTACGATAAACA-3′
11 F: 5′-TGTGCAGAGCCTCTGCATTG-3′
  R: 5′-TAATTACCTAAAGCGATTGT-3′
12 F: 5′-CATGCTGGTAGCTGCCATCC-3′
  R: 5′-TCTTTACCCAAGAGTCTGCT-3′
13 F: 5′-CCTGCAGGAGATGCCAAGGA-3′
  R: 5′-CACTTACCAAGCTGACTTCC-3′
14 F: 5′-CTTTTAGAAAAACAAATGTG-3′
  R: 5′-CACTTACCTGGAGGCTGCAG-3′
15 F: 5′-TCTTCAGCCAACAGACCTCA-3′
  R: 5′-ATCTTACCCTGGAAAACGCT-3′
16 F: 5′-CTTTCAGGCTTCCCAGAGGT-3′
  R: 5′-GACTCACCTAGTCGCACAGA-3′
17 F: 5′-TTTTCAGCCCCTGTCTATCA-3′
  R: 5′-TATGTTTCTTTGGTTTTATT-3′
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363was obtained from the participants before the collection of
their peripheral blood. Slit-lamp biomicroscopy and visual
acuity  and  fundus  examinations  were  performed  for  all
participating individuals to determine the disease phenotype.
Some of the first-degree relatives were also recruited when
available. Two probands with corneal dystrophies received
penetrating keratoplasty, and histopathological examinations
were performed on their corneal specimens.
Molecular genetic analysis: Genomic DNA was extracted
from the peripheral blood lymphocytes by using the Puregene
DNA  Purification  Blood  Kit  (Gentra,  Minneapolis,  MN)
according to the manufacturer’s instructions. Each exon of
TGFBI was amplified by polymerase chain reaction (PCR) by
using 50 ng of genomic DNA and a GeneAmp PCR system
9700 thermocycler (Applied Biosystems, Foster City, CA).
Primers used for amplifying each exon are listed in Table 1.
PCR was performed in 25-μl reaction mixtures containing 20
pmol  of  each  primer,  1×  reaction  buffer,  100  µM
deoxynucleotide triphosphates, and 1 unit of Taq polymerase
(Applied Biosystems). Touchdown PCR was performed for
all exons except exon 11. Cycling conditions were as follows:
initial preheating step at 95 °C for 11 min to achieve a hot start
effect, 12 cycles of denaturation at 95 °C for 30 s, initial
annealing at 63 °C for 30 s, and extension at 72 °C for 30 s;
the annealing temperature was reduced by 0.5 °C per cycle
until 56 °C. This was followed by 35 cycles of 95 °C for 30 s,
56 °C for 30 s, and 72 °C for 30 s, and a final extension step
at 72 °C for 10 min. The PCR cycling conditions for exon 11
included an initial denaturation at 95 °C for 2 min, followed
by 35 cycles of 95 °C for 30 s, 54 °C for 30 s, 72 °C for 30 s,
and a final extension step at 72 °C for 7 min. Exons 4 and 12
were sequenced first, followed by the sequencing of exons 11,
13, and 14; the remaining coding exons were sequenced later.
The resulting PCR products were purified using the QIAquick
PCR Purification Kit (Qiagen, Valencia, CA). Bidirectional
sequencing of amplicons was performed using the same PCR
forward and reverse primers with the BigDye terminator cycle
sequencer  kit  (Applied  Biosystems).  The  products  of  the
sequencing reaction were analyzed using a fluorescent ABI
Prism  3100  DNA  sequencer  (Perkin  Elmer  Applied
Biosystems, Warrington, UK).
Histopathological  examinations:  The  corneal  specimens
obtained using penetrating keratoplasty were processed for
examination by light microscopy. The tissues were fixed in
10% formalin and embedded in paraffin. The paraffin sections
were stained with hematoxylin and eosin (H&E), periodic
acid-Schiff (PAS), and Congo red stains.
RESULTS
Phenotypes: Of the 25 affected patients, 22 belonged to 12
families whose pedigrees are shown in Figure 1 and Figure 2,
and the remaining 3 (NTUH-4, NTUH-6, and NTUH-15)
were sporadic cases. Nine affected subjects from 6 families
(NTUH-1, NTUH-2, NTUH-6, NTUH-16, NTUH-22, and
NTUH-25)  presented  with  various  gray–white  granular
opacities  with  or  without  line  opacities.  The  number  of
granular  opacities  ranged  from  4  in  a  40-year-old  female
Figure 1. Pedigree of families with TGFBI-linked corneal dystrophies. Squares and circles represent male and female participants, respectively.
Open symbols indicate unaffected individuals, and solid symbols indicate affected members. Probands are marked by an arrow. Asterisks
indicate the members who underwent clinical examination and genetic analysis.
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364proband of the NTUH-2 family (Figure 3A) to more than 60
in  a  26-year-old  female  proband  of  the  NTUH-1  family
(Figure 3B). In the NTUH-2 family, the proband’s younger
sister had no remarkable opacities and had normal visual
acuity before laser-assisted in situ keratomileusis (LASIK)
surgery  according  to  medical  records  obtained  from  the
referring  doctor.  She  had  uncomplicated  bilateral  LASIK
surgery  elsewhere.  Six  months  after  the  operation,  some
crumb-like opacities and numerous fine confluent opacities
developed in the LASIK flap interface, and her visual acuity
declined to 20/100 in both eyes (Figure 3C). Most of the
crumb-like  opacities  in  these  families  were  elongated  or
stellate in shape except for some thin lines in the proband, a
57-year-old man, of the NTUH-6 family (Figure 3D). Four
affected subjects from 3 families (NTUH-3–5) had superficial
bread crumb–like or gray–white granular opacities, which
corresponded to GCD1 (Figure 3E). Six affected subjects
from  3  families  (NTUH-7,  NTUH-8,  and  NTUH-18)
presented  with  reticular-like  central  superficial  corneal
opacities  in  the  Bowman’s  layer  and  superficial  stroma
corresponding  to  CDB.  All  the  6  affected  subjects  had  a
history of recurrent corneal erosions since early childhood and
mild-to-moderate visual impairment. The proband (a 68-year-
old  man)  of  the  NTUH-18  family  received  penetrating
keratoplasty in the right eye (Figure 3F). The proband (a 40-
year-old man) of the NTUH-9 family and his elder son (age,
11  years)  showed  flake-dot  opacities  with  lattice-line
opacities in both eyes (Figure 3G). The parents of the proband
of the NTUH-9 family had clear corneas in both the eyes. The
proband (a 40-year-old man) of the NTUH-15 family had been
experiencing intermittent ocular irritation in both eyes for
several years. His corneas showed superficially central diffuse
opacities with some very faint fine lines in the periphery,
which was thinner and shorter than that observed in the case
of typical LCD1 (Figure 3H). He was initially diagnosed as
having CDB or atypical LCD1. The proband (a 42-year-old
woman) of the NTUH-11 family had small, polymorphic,
opaque dots with some filamentous lines in the central cornea
(Figure 3I). She had blurry vision since the second decade of
life without any episode of corneal erosion and had received
penetrating keratoplasty in the left eye. Her parents’ corneas
were normal and clear.
Molecular genetic analysis: Eight affected subjects from 5
families  (NTUH-1,  NTUH-2,  NTUH-16,  NTUH-22,  and
NTUH-25) had an R124H mutation, but the proband of the
NTUH-6 family had an R555W mutation (Figure 4A). All 4
affected subjects from the 3 families with GCD1 (NTUH-3–
5) had the R555W mutation. Six affected subjects from the 3
families with CDB (NTUH-7, NTUH-8, and NTUH-18) had
an R555Q mutation. The proband of the NTUH-15 family
with atypical LCD was found to have an R124C mutation
rather than the R555W or R124L mutation commonly noted
in  patients  with  CDB  (Figure  4B).  The  proband  of  the
NTUH-11 family with polymorphic opacities and some line
opacities had an A546D mutation (Figure 4C). Her parents
and son did not have this mutation (Figure 2A). The proband
of the NTUH-9 family with lattice lines and his affected son
had the R124C mutation, but the proband’s parents did not
have  this  mutation  in  TGFBI  (Figure  2B).  Five  distinct
TGFBI mutations were identified in these 15 families having
different subtypes of corneal dystrophies (Table 2).
Figure 2. Pedigrees of the NTUH-11 and
NTUH-9  families  with  TGFBI
sequences.  Open  symbols  indicate
unaffected  individuals,  and  solid
symbols  indicate  affected  members.
Probands are marked by an arrow. A:
The proband of the NTUH-11 family
had a A546D mutation in exon 12, but
her parents and son had normal TGFBI
sequences.  B:  The  proband  of  the
NTUH-9 family and his elder son had a
heterozygous C→T transition (R124C)
in exon 4, but the proband’s parents and
his younger son had TGFBI sequences
without this R124 mutation.
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365Histopathological examinations: Microscopic examination of
the corneal specimens obtained using penetrating keratoplasty
in  the  proband  of  the  NTUH-18  family  showed  irregular
epithelial thickness, vacuolization in the basal epithelium,
focal  disruption  of  the  Bowman’s  layer,  and  undulating
subepithelial  fibrosis  (Figure  5A,B).  Corneal  specimens
obtained after penetrating keratoplasty in the proband of the
NTUH-11  family  showed  numerous  eosinophilic  deposits
interspersed within the entire stromal layer (Figure 5C). These
deposits  showed  apple-green  birefringence  on  Congo  red
staining  under  polarized  light,  corresponding  to  amyloid
deposits (Figure 5D).
DISCUSSION
Mutations in TGFBI have often been identified in several
different  stromal/Bowman’s  layer  corneal  dystrophies,
including in GCD1, GCD2, RBCD (CDB1), TBCD (CDB2),
LCD1, and atypical LCDs [13]. The classic GCD1 with the
R555W mutation presents as multiple small white spots in the
Bowman’s layer and superficial corneal stroma. Most of our
Figure 3. Clinical phenotypes of TGFBI corneal dystrophies. A: Four round white opacities in the proband of the NTUH-2 family. B: Numerous
crumb-shaped opacities in the proband of the NTUH-1 family. C: Numerous sand-like opacities with some rod-dot granules in the LASIK
flap interface in the proband’s younger sister in the NTUH-2 family. D: Some dots with thin lines in the proband of the NTUH-6 family. E:
Superficial breadcrumb-like opacities in the proband of the NTUH-4 family. F: Superficial reticular opacities in the proband of the NTUH-18
family. G: Flake-dot opacities with lattice-line opacities in the proband of the NTUH-9 family. H: Superficially central diffuse haze with some
very fine and short lines in the periphery in the proband of the NTUH-15 family. I: Numerous small, polymorphic dots with some filamentous
lines in the proband of the NTUH-11 family.
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366patients with the R555W mutation showed the typical features
of  GCD1  noted  worldwide;  however,  the  proband  of  the
NTUH-6 family showed dot and line opacities, which have
rarely been reported in GCD1 with the R555W mutation. The
vision  of  patients  with  the  R555W  mutation  was  mildly
affected, with a range between 20/30 and 20/50. The discrete
round  opacities  in  our  GCD2  patients  with  the  R124H
mutation were larger than those noted in classical GCD1 and
occasionally  coexisted  with  line  opacities,  sharing  some
features with GCD1 and LCD. GCD2 is usually linked with
the  R124H  mutation  and  has  considerable  intra-  and
interfamilial  phenotypic  variation.  Wide  interfamilial
variation was also observed in our 5 GCD2 families. The
proband of the NTUH-2 family had few granular deposits
without any line opacities, unlike the other 4 families with
GCD2. In fact, this proband could have been misdiagnosed as
having GCD1 because GCD2, like GCD1, might show an
initial presentation of a few granular deposits. Our results
indicated  that  there  was  a  good  phenotype–genotype
correlation  in  most  patients  with  GCD1  and  GCD2,  but
phenotypic variation was noted in some cases.
Exacerbation  of  corneal  opacities  after  LASIK  was
observed in the younger sister of the proband of the NTUH-2
family  with  GCD2.  Several  reports  have  shown  rapid
acceleration  of  granular  corneal  opacities  after  LASIK  in
patients with GCD2 [14,15]. The increased deposits often
appeared in the flap interface and mainly within the ablation
zone,  suggesting  that  an  increased  production  of  TGFBI
protein by keratocytes in the region of corneal trauma was
related to lamellar corneal incision and excimer laser ablation.
Hence, we recommend that patients with GCD2 or any other
TGFBI-linked corneal dystrophies should not be considered
for  LASIK  surgery  because  the  corneal  opacities  in  the
interface might increase, and the vision may worsen after the
operation. Detailed examination of corneas and ensuring no
overlooking of any bilaterally subtle corneal opacity in the
Figure 4. TGFBI mutations in 3 families with corneal dystrophies. A: A heterozygous C→T transition (R555W) in exon 12 in the proband of
the NTUH-6 family. B: A heterozygous C→T transition (R124C) in exon 4 in the proband of the NTUH-15 family. C: A heterozygous C→A
transition (A546D) in exon 12 in the proband of the NTUH-11 family.
TABLE 2. CLINICAL PHENOTYPES AND GENOTYPES OF THE PROBANDS OF 15 FAMILIES WITH TGFBI-LINKED CORNEAL DYSTROPHIES.
Family Phenotype Mutations Age (proband) at
examination (years)
VA (proband) at examination
NTUH 1 Numerous granules and some stellate opacities R124H 26 OD: 0.7; OS: 0.7
NTUH 2 Some granular opacities R124H 29 OD: 1.0; OS: 0.6 (RD s/p SB)
NTUH 16 Numerous granules and some stellate opacities R124H 60 OD: 0.05; OS: 0.2 with cataract (OU)
NTUH 22 Numerous granules and some stellate opacities R124H 30 OD: 1.0; OS: 1.0
NTUH 25 Numerous granules and some stellate opacities R124H 68 OD: 0.5; OS: 0.5 with cataract (OU)
NTUH 6 Some granules with slim lines R555W 52 OD: 0.5; OS: 0.6
NTUH 3 Bread crumb opacities R555W 39 OD: 0.5; OS: 0.6
NTUH 4 Bread crumb opacities R555W 24 OD: 0.4; OS: 0.3
NTUH 5 Bread crumb opacities R555W 45 OD: 0.5; OS: 0.5
NTUH 7 Reticular superficial opacities R555Q 21 OD: 0.6; OS: 0.6
NTUH 8 Reticular superficial opacities R555Q 57 OD: 0.1; OS: 0.1 with cataract (OU)
NTUH 18 Reticular superficial opacities R555Q 68 OD: 0.05; OS: 0.05 with cataract (OU)
NTUH 9 Flake-dot opacities with lattice lines R124C 36 OD: 0.3; OS: 0.4
NTUH 15 Superficially diffuse haze with some fine lines R124C 32 OD: 0.4; OS: 0.4
NTUH 11 Polymorphic dots with lattice lines A546D 39 OD: 0.4; OS: 0.2
               OD: right eye, OS: left eye, OU: both eyes. RD s/p SB: retinal detachment after surgery with scleral buckle.
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367patients  referred  for  LASIK  surgery  is  important.  Further
genetic analysis of TGFBI in cases in which corneal dystrophy
is suspected can help identify patients with atypical GCD2 and
prevent  this  adverse  event  from  occurring  after  LASIK
surgery.
Patients with corneal opacities at the level of Bowman’s
layer have previously been diagnosed as having CDB, but
some of them were thought to have a superficial variant of
granular corneal dystrophy [16]. Typical RBCD (CDB1) and
TBCD (CDB2) are characterized by geographic opacities and
honeycomb-shaped  opacities,  respectively.  Most  patients
reported to have CDB1 had the R124L mutation and those
reported to have CDB2 had the R555Q mutation [17,18].
However, the R124L and R555Q mutations do not account for
all  forms  of  CDB.  Other  mutations  may  cause  similar
phenotypes,  including  a  ΔF540  mutation  described  in  a
Sardinian family and a G623D mutation [19,20]. In addition,
Yee  et  al.  [21]  reported  a  family  with  TBCD  showing
“peculiar curly” filaments in the sub-epithelial layer of the
cornea.  This  trait  was  mapped  to  chromosome  10q23–24
instead of the TGFBI locus at 5q31. Although these reports
suggest the phenotypic and genetic heterogeneity inherent in
CDB, our study in the 6 patients of our 3 CDB families
indicated that patients with TBCD would have characteristic
presentation of honeycomb corneal opacities at the Bowman’s
layer and superficial stroma, and were correlated with the
R555Q  mutation.  Histology  of  these  honeycomb  corneal
opacities  was  an  undulating  fibrous  tissue  in  the
subepithelium  and  focal  disruption  of  the  Bowman’s
membrane. However, histology may not be available in all
patients with CDB. Genetic study of TGFBI can be accurate
Figure 5. Histopathology. A: The corneal specimen from the proband of the NTUH-18 family showed irregular thickness of the epithelium,
vacuolization in the basal epithelium, and focal subepithelial fibrosis interposed between the irregular epithelium with a “sawtooth-like”
configuration (PAS staining, 200×). B: Focal disruption of Bowman’s membrane (arrows) was replaced by subepithelial fibrotic tissue (star)
(H&E staining, 400×). C: The specimen from the proband of the NTUH-11 family showed several eosinophilic deposits interspersed within
the entire corneal stromal layer (H&E staining, 200×). D: These deposits showed green birefringence under a polarized microscope (Congo
red staining, 200×).
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368to classify these CDB because of a good genotype-phenotype
correlation in TBCD/R555Q.
LCD1  is  characterized  by  a  network  of  delicate
interdigitating  filaments  within  the  corneal  stroma.  The
disease  usually  begins  in  the  first  decade  of  life  with
symptoms  of  recurrent  painful  epithelial  erosions.  Lattice
lines and diffuse opacification of the central cornea develop
gradually after the erosions and amyloid accumulations. The
most common mutation in TGFBI in patients with LCD1 is
R124C. Numerous forms of atypical LCD have been reported
to  be  caused  by  P501T,  V505D,  L518P,  I522N,  L527R,
V539D, A546D, A546T, P551Q, L569R, H572R, V625D, or
H626R  mutations  [22-27].  The  proband  of  the  NTUH-11
family had the A546D mutation and blurred vision, with no
history  of  recurrent  corneal  erosion.  She  presented  with
polymorphic refractile dots and filamentous lines in the deep
stroma, which were unlike those found in typical LCD1. The
histological examination showed amyloidal deposits in the
entire stromal layer. These findings were similar to the cases
of polymorphic corneal amyloidosis first described by Eifrig
et  al.  [25].  However,  2  reports  revealed  that  the  A546D
mutation could also cause phenotypes of either atypical LCD
or GCD1 [28,29]. Reports of the A546D mutation in TGFBI
have been rare. This mutation might result in different clinical
phenotypes.
Interestingly, the proband of the NTUH-15 family with
the R124C mutation had diffuse central grayish opacities in
the  subepithelium  and  superficial  stroma  without  typical
branching  refractile  lattice  lines  that  are  characteristic  of
LCD1.  Unfortunately  no  histology  was  available  in  this
proband, but these superficial opacities were more similar to
CDB than to typical LCD1. Several studies have reported
similar findings. For instance, a Chinese family with RBCD
had  the  R124C  mutation  instead  of  the  common  R124L
mutation, and a family from New Zealand with atypical CDB
had the H626P mutation, a known mutation linked to variant
LCD [30,31]. These results indicate that phenotypic variabilty
may occur in patients with R124C or H626P mutations, which
segregate  with  phenotypes  of  either  CDB  or  LCD.  The
superficial stromal opacities in this proband with the R124C
mutation were not like classic TBCD, RBCD, or LCD1. This
atypical  presentation  may  be  due  to  interaction  between
TGFBI and other genes or the effect of environmental factors
on gene presentation.
Spontaneous  mutations  in  the  TGFBI  gene  have
previously been reported, including an R124L mutation in 2
patients with RBCD and an R555Q mutation in 2 families with
CDB [32,33]. In our study, spontaneous mutations were found
in 2 families, one with an R124C mutation and another with
an A546D mutation. In addition, the spontaneously mutated
allele could be transmitted to the next generation. Most of the
reported spontaneous mutations in the TGFBI gene are at the
2 common hotspots, namely, R124 and R555, and involve a
G:C→A:T  transition  more  frequently  than  an  A:T→G:C
transition  [34].  Spontaneous  mutation  of  A546D  with  an
A→C transition has not yet been reported.
Our  study  showed  that  codons  R124  and  R555  of
TGFBI were the 2 mutational hotspots in autosomal dominant
corneal dystrophies in Taiwan, as they were in other ethnic
groups.  Interestingly,  the  predominant  mutations  varied
across different countries. For example, the classic GCD1/
R555W mutation is the most prevalent mutation in Europe.
The GCD2/R124H mutation is the most common mutation in
Japan and Korea [35,36]. The GCD1/R555W and GCD2/
R124H mutations are the 2 most common mutations in China.
The GCD1/R555W and LCD1/R124C mutations are the 2
most common mutations in India [37]. The LCD/H626R and
GCD1/R555W mutations are the 2 most common mutations
in  Mexico  [38].  The  GCD1/R555W  is  the  most  common
mutation  in  New  Zealand  [39].  The  pattern  of  TGFBI
mutations showed some correlations among these Northeast
Asian countries and India, but not Vietnam, LCD/H626R
more predominant than LCD1/R124C [40]. In our study, the
GCD2/R124H and GCD1/R555W mutations were the 2 most
common mutations in Taiwan, as has been reported in China.
This may be due to the shared ancestry between the Taiwanese
and  Chinese  populations.  Interestingly,  the  TBCD/R555Q
mutation (3/15) in our study was not rare as in China (1/64)
or Japan (6/286). This may be related to the founder effect, a
bias  of  a  small  sample  size,  the  influence  of  admixture
between the Taiwanese ancestral population and the local
South  Polynesian  population,  or  spontaneous  TGFBI
mutations. Phylogenetic trees and correspondence analysis
calculated from human leukocyte antigens allele frequencies
have shown that Taiwanese have a more affinity to southern
Asian  population  than  northern  Han  Chinese  or  Japanese
[41].  Our  results  of  TGFBI  mutations  in  Taiwanese  were
correspondence  to  these  findings.  A  close  relationship
between Taiwan indigenous people and Oceanians, and 13%
of Taiwan indigenous genes in Taiwanese gene pool were also
found  [42].  It  may  explain  this  unique  result  of  TGFBI
mutations in Taiwanese. Further large-scale studies involving
more  Taiwanese  families  with  TGFBI-linked  corneal
dystrophies are required to confirm our preliminary findings
and the speculation of the relationship between Taiwanese and
other Asian population. More reports on TGFBI mutations
from other Southeast Asian or Pacific Ocean countries might
help clarify the difference between ethnic background and
genotypes and understand their possible relationship across
different countries.
In conclusion, a good phenotype–genotype correlation
was observed in most patients with TGFBI-linked corneal
dystrophies.  Intra-  and  interfamilial  phenotypic  variation
occurred occasionally. Genetic screening of TGFBI might
facilitate  precise  clinical  diagnosis  and  corneal  dystrophy
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369classification,  especially  in  patients  with  atypical
presentation.
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